Learning whether to subtract beta-blockers: it's about time.

Journal Article (Editorial)

Proposed framework for foundational and provisional secondary prevention therapy over time in low-risk post-MI patients. Foundational therapies should be considered in all patients without contraindications, while provisional therapies should be considered in selected patients with comorbidities or post-infarction complications. The horizontal time axis proposes duration of therapies and timeframes for pharmacotherapeutic re-assessment, and should be responsive to the temporal evolution of post-MI risk and events. ADP, adenosine diphosphate receptor inhibitors; ASA, acetylsalicylic acid; CKD, chronic kidney disease; DM, diabetes mellitus; HTN, hypertension; RAAS, renin-angiotensin-aldosterone system; RCT, randomized controlled trials; TG, triglyceride. *Pending guideline recommendations.

Full Text

Duke Authors

Cited Authors

  • van Diepen, S; Armstrong, PW

Published Date

  • March 1, 2021

Published In

Volume / Issue

  • 42 / 9

Start / End Page

  • 915 - 918

PubMed ID

  • 33428708

Electronic International Standard Serial Number (EISSN)

  • 1522-9645

Digital Object Identifier (DOI)

  • 10.1093/eurheartj/ehaa1033


  • eng

Conference Location

  • England